(MedPage Today) — NEW ORLEANS — An investigational triple-receptor agonist made some headway in patients with severe hypertriglyceridemia, a phase II study showed.
One Chinese cohort had triglycerides slashed from around 800 mg/dL at baseline…
Source link : https://www.medpagetoday.com/meetingcoverage/aha/118386
Author :
Publish date : 2025-11-08 14:30:00
Copyright for syndicated content belongs to the linked Source.
